Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
Thijs Ten DoesschateSuzan P van MensCees van NieuwkoopSuzanne E GeerlingsAndy I M HoepelmanMarc J M BontenPublished in: BMC infectious diseases (2018)
NTR6449 . Secondary ID (national authority): NL60186.041.17.